Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T Mutis
The Therapeutic Human CD38 Antibody Daratumumab Improves the Anti-Myeloma Effect of Newly Emerging Multi-Drug Therapies
Blood Cancer Journal
Oncology
Hematology
Minor Histocompatibility Ags: Identification Strategies, Clinical Results and Translational Perspectives
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Daratumumab Induces CD38 Internalization and Impairs Myeloma Cell Adhesion
OncoImmunology
Oncology
Allergy
Immunology
The Mechanism of Action of the Anti-Cd38 Monoclonal Antibody Isatuximab in Multiple Myeloma
Clinical Cancer Research
Cancer Research
Oncology
Daratumumab in Untreated Newly Diagnosed Multiple Myeloma
Therapeutic Advances in Hematology
Hematology
Mechanism of Action of a New Anti-Cd38 Antibody: Enhancing Myeloma Immunotherapy
Clinical Cancer Research
Cancer Research
Oncology
Daratumumab-Mediated Lysis of Primary Multiple Myeloma Cells Is Enhanced in Combination With the Human Anti-Kir Antibody IPH2102 and Lenalidomide
Haematologica
Hematology
Phase I Study of the Anti-FcRH5 Antibody-Drug Conjugate DFRF4539A in Relapsed or Refractory Multiple Myeloma
Blood Cancer Journal
Oncology
Hematology
Novel Therapies in Multiple Myeloma for Newly Diagnosed Nontransplant Candidates
Cancer Journal
Cancer Research
Oncology
CD38: From Positive to Negative Expression After Daratumumab Treatment
Cureus
Structural Characterization of a Potent Humanized Anti-Cd38 Antibody in Phase I
Acta Crystallographica Section A: Foundations and Advances
Materials Science
Condensed Matter Physics
Theoretical Chemistry
Biochemistry
Structural Biology
Inorganic Chemistry
Physical